Results 1 to 10 of about 28,373 (234)

Treatment with an Anti-CD44v10-Specific Antibody Inhibits the Onset of Alopecia Areata in C3H/HeJ Mice [PDF]

open access: bronze, 2000
A murine CD44v10-neutralizing antibody has been reported to impair delayed-type hypersensitivity reactions. Because alopecia areata is characterized by a delayed-type hypersensitivity-like T cell mediated immune response, we addressed the question ...
Pia Freyschmidt‐Paul   +7 more
openalex   +4 more sources

Alopecia Areata Associated with Localized Vitiligo [PDF]

open access: yesCase Reports in Dermatology, 2010
Alopecia areata is a common cause of noncicatricial alopecia that occurs in a patchy, confluent or diffuse pattern. It may occur as a single, self-limiting episode or may recur at varying intervals over many years. The association of alopecia areata with
Shankarling D. Kuchabal, D.S. Kuchabal
doaj   +4 more sources

Etrasimod for alopecia areata: The scenario for a less extensive and moderate form. [PDF]

open access: yesJ Eur Acad Dermatol Venereol
Journal of the European Academy of Dermatology and Venereology, Volume 39, Issue 6, Page 1076-1077, June 2025.
Starace M.
europepmc   +2 more sources

Alopecia areata. Diagnostic and therapeutic recommendations of the Polish Dermatological Society. Part 1. Diagnosis and severity assessment

open access: yesPrzegląd Dermatologiczny, 2023
The existence of two types of alopecia areata is suggested (probably genetically different): early-onset, with more severe symptoms, longer disease duration, higher tendency to relapse, often with a positive family history, and late-onset, in which the ...
Adriana Rakowska   +8 more
doaj   +1 more source

Alopecia areata. Diagnostic and therapeutic recommendations of the Polish Society of Dermatology. Part 2: Treatment

open access: yesPrzegląd Dermatologiczny, 2023
The treatment goal in alopecia areata is induction of hair regrowth and halting the progression of the disease. Treatment decisions depend on the severity of the alopecia areata as assessed by the Severity of Alopecia Tool (SALT) or the Alopecia Areata ...
Adriana Rakowska   +8 more
doaj   +1 more source

Progress in immune pathogenesis and targeted therapy of alopecia areata

open access: yesPifu-xingbing zhenliaoxue zazhi, 2023
Alopecia areata is a common clinical non-cicatricial alopecia. Alopecia totalis and generalized alopecia may occur in severe cases. The pathogenesis of alopecia areata is complex, and the treatment is faced with many difficulties.
Jiali WANG   +3 more
doaj   +1 more source

Alopecia Areata as a Proximal Risk Factor for the Development of Comorbid Depression: A Population-based Study

open access: yesActa Dermato-Venereologica, 2022
Alopecia areata and depression tend to co-occur; however, their temporal association has not been comprehensively investigated. The aim of this study was to examine the temporal association between alopecia areata and depression.
Dana Tzur Bitan   +4 more
doaj   +1 more source

Hair and Scalp Disease Detection using Machine Learning and Image Processing [PDF]

open access: yesEJ-Compute.2023;3(1):7-13, 2022
Almost 80 million Americans suffer from hair loss due to aging, stress, medication, or genetic makeup. Hair and scalp-related diseases often go unnoticed in the beginning. Sometimes, a patient cannot differentiate between hair loss and regular hair fall.
arxiv   +1 more source

Serum Zinc Concentration in Patients with Alopecia Areata

open access: yesActa Dermato-Venereologica, 2023
Alopecia areata is an autoimmune non-scarring disease in which the exact mechanism that induces loss of immune privilege is unknown. Zinc is important for DNA stability and repair mechanisms that are essential in maintaining normal hair growth.
Jovan Lalosevic   +3 more
doaj   +1 more source

Alopecia Areata Occurring after COVID-19 Vaccination: A Single-Center, Cross-Sectional Study

open access: yesVaccines, 2022
Limited data concerning the development of autoimmune skin diseases after COVID-19 vaccination are currently available. Recently, a few reports described the development, worsening or recurrence of alopecia areata after the administration of COVID-19 ...
Francesco Tassone   +5 more
doaj   +1 more source

Home - About - Disclaimer - Privacy